R
Renyi Wu
Researcher at Rutgers University
Publications - 47
Citations - 1759
Renyi Wu is an academic researcher from Rutgers University. The author has contributed to research in topics: Epigenetics & DNA methylation. The author has an hindex of 19, co-authored 45 publications receiving 1167 citations. Previous affiliations of Renyi Wu include Chinese Academy of Sciences.
Papers
More filters
Journal ArticleDOI
An Update on Current Therapeutic Drugs Treating COVID-19.
Renyi Wu,Lujing Wang,Hsiao-Chen Dina Kuo,Ahmad Shannar,Rebecca Peter,Pochung Jordan Chou,Shanyi Li,Rasika Hudlikar,Xia Liu,Xia Liu,Zhigang Liu,George J. Poiani,George J. Poiani,Louis F. Amorosa,Luigi Brunetti,Luigi Brunetti,Ah-Ng Tony Kong +16 more
TL;DR: It is hoped that this review will provide useful and most updated therapeutic drugs to prevent, control, and treat COVID-19 patients until the approval of vaccines and specific drugs targeting SARS-CoV-2.
Journal ArticleDOI
DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice.
Yue Guo,Renyi Wu,John M. Gaspar,Davit Sargsyan,Zheng-Yuan Su,Zheng-Yuan Su,Chengyue Zhang,Linbo Gao,David Cheng,Wenji Li,Chao Wang,Ran Yin,Mingzhu Fang,Michael P. Verzi,Ronald P. Hart,Ah-Ng Tony Kong +15 more
TL;DR: Epigenomic changes in DNA CpG methylation in the inflammatory response from colitis-associated colon cancer and the reversal of their Cpg methylation changes by curcumin are shown for the first time.
Journal ArticleDOI
Dietary Phytochemicals and Cancer Chemoprevention: A Perspective on Oxidative Stress, Inflammation, and Epigenetics.
TL;DR: The beneficial effects of dietary phytochemicals on cancer development warrant further investigation to provide additional impetus for clinical translational studies.
Journal ArticleDOI
Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA-194.
TL;DR: The results indicate that miR-194 downregulates the expression of oncogenic MMP2 and MMP9 by targeting BMP1, which suggests a potential new mechanistic target by which PEITC suppresses prostate cancer cell invasiveness.
Journal ArticleDOI
The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells.
Qian Zuo,Qian Zuo,Renyi Wu,Xi Xiao,Cai-Zhi Yang,Yuqing Yang,Chao Wang,Lizhu Lin,Ah-Ng Tony Kong +8 more
TL;DR: The findings suggest that LUT may exert its antitumor activity in part via epigenetic modifications of the Nrf2 gene with subsequent induction of its downstream antioxidative stress pathway.